Ronald Muhlenkamp is the founder and president of Muhlenkamp & Company Inc. and the portfolio manager for the company's mutual fund. His portfolio is composed of 64 stocks with a total value of $340 million. The following are the stocks in his portfolio with the highest growing yield.
JPMorgan Chase & Co. (JPM) pays its shareholders an annual dividend yield of 2.57% with a payout ratio of 29%. The yield has a five-year growth rate of 60%.
JPMorgan had decent results for the third quarter in which net income grew by 22% and net revenue declined by 6%.
The stock is trading at the price of $67.39. The DCF calculator gives a fair value of $92.41 with a margin of safety of 27%, while the Peter Lynch earnings line gives a fair value of $85.6.
JPMorgan is trading with a P/E ratio of 11.43. During the last 12 months, the price has risen by 10% and is now trading 4.56% below its 52-week high and 34.59% above its 52-week low.
The company's main shareholder among the gurus is James Barrow (Trades, Portfolio) with a 0.9% stake, followed by Dodge & Cox with 0.71% and Chris Davis (Trades, Portfolio) with 0.5% of outstanding shares.Â
Teva Pharmaceutical Industries Ltd. (TEVA) pays its shareholders an annual dividend yield of 2.26% with a payout ratio of 65%. The yield has a five-year growth rate of 23.2%.
The company manufactures generic pharmaceutical products. The stock is trading at the price of $59.77. The DCF calculator gives a fair value of $24.63, so the company currently looks overpriced by 40%. The Peter Lynch earnings line gives a fair value of $33.8.
Teva Pharmaceutical is trading with a P/E ratio of 28.86. During the last 12 months, the price has risen by 3% and is now trading 17.34% below its 52-week high and 10.34% above its 52-week low.
James Barrow (Trades, Portfolio) is the company's leading shareholder among the gurus with a stake of 1.16%, followed by the firms First Eagle Investment (Trades, Portfolio) with 0.52% and NWQ Managers (Trades, Portfolio) with 0.35%. Muhlenkamp holds 0.2% of outstanding shares, which is 2.94% of his total assets.
Microsoft Corp. (MSFT) pays its shareholders an annual dividend yield of 2.62% with a payout ratio of 83%. The yield has a five-year growth rate of 18.90%.
During the first quarter of 2016, the company delivered strong results in which operating income grew by 11% and it had a 16% increase in its quarterly dividend.
The stock is trading at the price of $54.16. The DCF calculator gives a fair value of $17.54 so the company currently looks overpriced by 209%, while the Peter Lynch earnings line gives a fair value of $22.1.
Microsoft is trading with a P/E ratio of 36.18. During the last 12 months, the price has risen by 11%, and is now trading 1.49% below its 52-week high and 36.35% above its 52-week low.
The company's main shareholder is the firm Dodge & Cox with a stake of 1.02% of outstanding shares followed by the investor Jeff Ubben (Trades, Portfolio) with 0.94% and the firm PRIMECAP Management (Trades, Portfolio) with 0.79% of outstanding shares.
Schlumberger Ltd. (SLB) pays its shareholders an annual dividend yield of 2.53% with a payout ratio of 72% and the yield has a five-year growth rate of 13.80%.
The company is a supplier of technology, integrated project management and information solutions to the international oil and gas exploration and production industry. Its business segments are Reservoir Characterization Group, Drilling Group and Production Group.
The stock is trading at the price of $77.91. The DCF calculator gives a fair value of $44.24, so the company currently looks overpriced by 76%. The Peter Lynch earnings line gives a fair value of $45.1
Schlumberger is trading with a P/E ratio of 29.40. During the last 12 months, the price has dropped by 21% and is now trading 22.51% below its 52-week high and 17.03% above its 52-week low.
Dodge & Cox is the company's leading guru shareholder with a stake of 4.51%, followed by Frank Sands (Trades, Portfolio) with 1.25% and Manning & Napier Advisors with 0.54%.Â
Halliburton Co. (HAL) pays its shareholders an annual dividend yield of 1.83% with a payout ratio of 234%, and the yield has a five-year growth rate of 11.90%.
The company is a provider of services and products to the energy industry related to the exploration, development, and production of oil and natural gas. It serves national and independent oil and natural gas companies. The company's two business segments are Completion and Production, and Drilling and Evaluation.
During the third quarter, total revenues declined by 6%, while adjusted operating income declined 21%.
The stock is trading at the price of $39.1. The DCF calculator gives a fair value of $5.18, so the company currently looks overpriced by 655%. The Peter Lynch earnings line gives a fair value of $1511.
Halliburton is trading with a P/E ratio of 129.90. During the last 12 months the price has dropped by 27% and is now trading 32.59% below its 52-week high and 26.41% above its 52-week low.
The company's main shareholder among the gurus is Jeff Ubben (Trades, Portfolio) with a stake of 4.38%, followed by Glenn Greenberg (Trades, Portfolio) with 0.67% and Tweedy Browne with 0.62% of outstanding shares.Â
Energy Transfer Equity LP (ETE) pays its shareholders an annual dividend yield of 5.87% with a payout ratio of 103%. The yield has a five-year growth rate of 7.10%.
The stock is trading at the price of $19.42. The DCF calculator gives a fair value of $5.63, so the company currently looks overpriced by 245%, while the Peter Lynch earnings line gives a fair value of $9.8.
Energy Transfer Equity is trading with a P/E ratio of 28.69. During the last 12 months, the price has dropped by 37% and is now trading 45.20% below its 52-week high and 4.30% above its 52-week low.
John Burbank (Trades, Portfolio) is the company's leading guru shareholder with a stake of 0.602% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio), Ron Baron (Trades, Portfolio) and Jim Simons (Trades, Portfolio) with 0.01%.Â
Pfizer Inc. (PFE) pays its shareholders an annual dividend yield of 3.30% with a payout ratio of 77%. The yield has a five-year growth rate of 6.70%.
It is a research-based, biopharmaceutical company. The company applies science and its resources to bring therapies to people that extend and improve their lives through the discovery, development and manufacture of healthcare products.
During the third quarter, operational revenues grew by 6% and adjusted diluted EPS increased by 5% compared to the same quarter of a year before. Net income grew by 20%.
The stock is trading at the price of $33.65. The DCF calculator gives a fair value of $10.97, so the company currently looks overpriced by 207%, while the Peter Lynch earnings line gives a fair value of $20.7.
Pfizer is trading with a P/E ratio of 23.75. During the last 12 months, the price has risen by 11% and is now trading 45.20% below its 52-week high and 4.30% above its 52-week low.
The company's leading shareholder among the gurus is James Barrow (Trades, Portfolio) with a stake of 0.9%, followed by the firm Dodge & Cox with 0.73% and Ken Fisher (Trades, Portfolio) with 0.52%.Â
